169 related articles for article (PubMed ID: 34747496)
1. High-mobility group box 1 as a predictive biomarker for drug-resistant epilepsy: A proof-of-concept study.
Walker LE; Sills GJ; Jorgensen A; Alapirtti T; Peltola J; Brodie MJ; Marson AG; Vezzani A; Pirmohamed M
Epilepsia; 2022 Jan; 63(1):e1-e6. PubMed ID: 34747496
[TBL] [Abstract][Full Text] [Related]
2. High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy.
Ravizza T; Terrone G; Salamone A; Frigerio F; Balosso S; Antoine DJ; Vezzani A
Brain Behav Immun; 2018 Aug; 72():14-21. PubMed ID: 29031614
[TBL] [Abstract][Full Text] [Related]
3. Serum concentration of high-mobility group box 1, Toll-like receptor 4 as biomarker in epileptic patients.
Yue Z; Tang J; Peng S; Cai X; Rong X; Yang L
Epilepsy Res; 2023 May; 192():107138. PubMed ID: 37075527
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Review of the Predictive and Diagnostic Uses of Neuroinflammation Biomarkers for Epileptogenesis.
Aguilar-Castillo MJ; Cabezudo-García P; García-Martín G; Lopez-Moreno Y; Estivill-Torrús G; Ciano-Petersen NL; Oliver-Martos B; Narváez-Pelaez M; Serrano-Castro PJ
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928193
[TBL] [Abstract][Full Text] [Related]
5. Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy.
Walker LE; Frigerio F; Ravizza T; Ricci E; Tse K; Jenkins RE; Sills GJ; Jorgensen A; Porcu L; Thippeswamy T; Alapirtti T; Peltola J; Brodie MJ; Park BK; Marson AG; Antoine DJ; Vezzani A; Pirmohamed M
J Clin Invest; 2017 Jun; 127(6):2118-2132. PubMed ID: 28504645
[TBL] [Abstract][Full Text] [Related]
6. CSF high-mobility group box 1 is associated with drug-resistance and symptomatic etiology in adult patients with epilepsy.
Wang N; Liu H; Ma B; Zhao T; Chen Y; Yang Y; Zhao P; Han X
Epilepsy Res; 2021 Nov; 177():106767. PubMed ID: 34543830
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of an anti-high mobility group box-1 monoclonal antibody in epilepsy.
Zhao J; Wang Y; Xu C; Liu K; Wang Y; Chen L; Wu X; Gao F; Guo Y; Zhu J; Wang S; Nishibori M; Chen Z
Brain Behav Immun; 2017 Aug; 64():308-319. PubMed ID: 28167116
[TBL] [Abstract][Full Text] [Related]
8. High mobility group box 1 (HMGB1) as a novel frontier in epileptogenesis: from pathogenesis to therapeutic approaches.
Paudel YN; Semple BD; Jones NC; Othman I; Shaikh MF
J Neurochem; 2019 Dec; 151(5):542-557. PubMed ID: 30644560
[TBL] [Abstract][Full Text] [Related]
9. High Mobility Group Protein B1 (HMGB1) and Interleukin-1β as Prognostic Biomarkers of Epilepsy in Children.
Zhu M; Chen J; Guo H; Ding L; Zhang Y; Xu Y
J Child Neurol; 2018 Dec; 33(14):909-917. PubMed ID: 30303442
[TBL] [Abstract][Full Text] [Related]
10. High mobility group box 1 enhances hyperthermia-induced seizures and secondary epilepsy associated with prolonged hyperthermia-induced seizures in developing rats.
Ito M; Takahashi H; Yano H; Shimizu YI; Yano Y; Ishizaki Y; Tanaka J; Ishii E; Fukuda M
Metab Brain Dis; 2017 Dec; 32(6):2095-2104. PubMed ID: 28879430
[TBL] [Abstract][Full Text] [Related]
11. Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.
Pauletti A; Terrone G; Shekh-Ahmad T; Salamone A; Ravizza T; Rizzi M; Pastore A; Pascente R; Liang LP; Villa BR; Balosso S; Abramov AY; van Vliet EA; Del Giudice E; Aronica E; Antoine DJ; Patel M; Walker MC; Vezzani A
Brain; 2017 Jul; 140(7):1885-1899. PubMed ID: 28575153
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of MicroRNA-34c-5p facilitated neuroinflammation in drug-resistant epilepsy.
Fu M; Tao J; Wang D; Zhang Z; Wang X; Ji Y; Li Z
Brain Res; 2020 Dec; 1749():147130. PubMed ID: 32950487
[TBL] [Abstract][Full Text] [Related]
13. Circulating high mobility group box-1 and toll-like receptor 4 expressions increase the risk and severity of epilepsy.
Kan M; Song L; Zhang X; Zhang J; Fang P
Braz J Med Biol Res; 2019; 52(7):e7374. PubMed ID: 31241711
[TBL] [Abstract][Full Text] [Related]
14. Correlation of MMP-9 and HMGB1 expression with the cognitive function in patients with epilepsy and factors affecting the prognosis.
Huang Q; Liu J; Shi Z; Zhu X
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):39-47. PubMed ID: 32538745
[TBL] [Abstract][Full Text] [Related]
15. High mobility group box 1 antibody represses autophagy and alleviates hippocampus damage in pilocarpine-induced mouse epilepsy model.
Ying C; Ying L; Yanxia L; Le W; Lili C
Acta Histochem; 2020 Feb; 122(2):151485. PubMed ID: 31870503
[TBL] [Abstract][Full Text] [Related]
16. Targeting high-mobility group box protein 1 (HMGB1) in pediatric traumatic brain injury: Chronic neuroinflammatory, behavioral, and epileptogenic consequences.
Webster KM; Shultz SR; Ozturk E; Dill LK; Sun M; Casillas-Espinosa P; Jones NC; Crack PJ; O'Brien TJ; Semple BD
Exp Neurol; 2019 Oct; 320():112979. PubMed ID: 31229637
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of HMGB1 and pro-inflammatory cytokines in children with febrile seizures.
Choi J; Min HJ; Shin JS
J Neuroinflammation; 2011 Oct; 8():135. PubMed ID: 21989210
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures.
Maroso M; Balosso S; Ravizza T; Liu J; Aronica E; Iyer AM; Rossetti C; Molteni M; Casalgrandi M; Manfredi AA; Bianchi ME; Vezzani A
Nat Med; 2010 Apr; 16(4):413-9. PubMed ID: 20348922
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serum high-mobility group box 1 concentration in dogs with epilepsy: A case-control study.
Koo Y; Kim H; Yun T; Jung DI; Kang JH; Chang D; Na KJ; Yang MP; Kang BT
J Vet Intern Med; 2020 Nov; 34(6):2545-2554. PubMed ID: 33150666
[TBL] [Abstract][Full Text] [Related]
20. Naturally Occurring HMGB1 Inhibitor, Glycyrrhizin, Modulates Chronic Seizures-Induced Memory Dysfunction in Zebrafish Model.
Paudel YN; Khan SU; Othman I; Shaikh MF
ACS Chem Neurosci; 2021 Sep; 12(18):3288-3302. PubMed ID: 34463468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
